Country Reports - Pharmaceutical Executive


Country Reports

The Capital of the Future

September 1, 2011

Gujarati has become one of India's most industrialized states

Serbia: Ready to Flourish

August 1, 2011

Having progressively improved its financial standings over the past decade, this Eastern European market is now a bastion of potential—to the tune of $1.2 billion

Poland: A Sleeping Giant

July 1, 2011

A country that bridges East and West, old and new—while boasting a growing economy in Europe—is being looked to for its pool of talented industry resources

Malaysia: The Overlooked Emerging Market

May 1, 2011

Rising income per capita and a budding consumer health consciousness are fueling a CAGR of 9.5%, giving investors plenty of room to expand market penetration

Country Reports : France: The French Pharma Revolution

April 7, 2011

In France, it took a president's keynote speech to underscore the government's new understanding that there is more to pharmaceuticals than cost-containment

The Netherlands: Innovation through Collaboration

March 1, 2011

Despite its dimunitive size, the pharmaceutical industry looks to the Netherlands for a world-class medical infrastructure, new standards in innovation, and a closely-knit community of stakeholders

China: Big Pharma's Long March to End?

December 1, 2009

China's explosive growth in R&D is putting the natiion on its way to becoming the world's second-largest market by 2020


September 1, 2008

India: An Emerging Knowledge Superpower

September 1, 2007

"India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we are on our way to become a R&D hub." For Dilip Shah, General Secretary of the Indian Pharmaceutical Alliance (IPA), India is currently on its way to undertake one of the greatest transformations ever experienced within the pharmaceutical industry, although the excitement has been over 30 years in the making.


Click here